Market cap
₹512 Cr
Revenue (TTM)
₹0 Cr
P/E Ratio
--
P/B Ratio
12.8
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹-1 Cr
-
ROE
51.7 %
-
ROCE
51.7 %
-
Industry P/E
--
-
EV/EBITDA
-664.5
-
Debt to Equity
0
-
Book Value
₹8.9
-
EPS
₹-0.5
-
Face value
10
-
Shares outstanding
45,250,000
10 Years Aggregate
CFO
₹-6.22 Cr
EBITDA
₹-4.46 Cr
Net Profit
₹-0.51 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Genesis IBRC India
| 32.8 | -3.1 | 9.6 | 460.4 | -- | -- | -- |
|
BSE Healthcare
| 9.3 | 0.6 | 11.8 | 9.5 | 23.7 | 13.8 | 12.3 |
|
Company
|
2025
|
2020
|
|---|---|---|
|
Genesis IBRC India
| 386.2 | -3.7 |
|
BSE Small Cap
| -6.6 | 32.1 |
|
BSE Healthcare
| -3.3 | 61.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Genesis IBRC India
|
113.3 | 512.5 | 0.0 | -0.7 | -- | -3 | -- | 12.8 |
| 798.1 | 44,943.0 | 2,124.3 | 591.8 | 32.9 | 21 | 75.9 | 14.8 | |
| 788.5 | 40,830.5 | 4,643.2 | 464.1 | 13.7 | 8.9 | 105.2 | 8.9 | |
| 444.8 | 14,093.1 | 2,080.1 | 168.1 | 14.1 | 6.7 | 105.8 | 7.0 | |
| 1,662.9 | 27,827.9 | 2,762.9 | 509.8 | 22.5 | 21.5 | 55.1 | 11.1 | |
| 80.0 | 160.7 | 61.5 | 1.1 | 5.2 | -0.3 | 139.6 | 2.2 | |
| 789.8 | 31,661.0 | 3,904.6 | 239.4 | 13.3 | 11.1 | 131.2 | 14.1 | |
| 1,450.0 | 14,723.5 | 1,703.1 | 281.5 | 23.1 | 17.7 | 52.9 | 8.9 | |
| 1,305.6 | 13,416.7 | 814.2 | 173.0 | 30.1 | 19 | 77.6 | 14.0 | |
| 567.1 | 2,531.0 | 407.3 | 77.5 | 24.0 | 18.9 | 32.7 | 5.6 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Genesis IBRC India
Genesis IBRC India Limited engages in the manufacture and marketing of pro-biotic products for aquaculture, agriculture, poultry, and animal husbandry markets in India. The company's products include GENPRO-WAT water and soil probiotic, Pro-VIBSOL... vibro controller, AMMONO-GEN ammonia and nitrites reducing probiotic, GENLACT gut and intestinal probiotic, GROWFAST-GEN single cell protein, and GEN-POND CLEAN fast decomposer. It also provides formulation research and development services for aquaculture bio formulations and feed supplements, poultry bio formulations, and veterinary bio formulations, as well as agriculture bio formulations and plant, and seaweed extracts; need based product design services; mobile and land lab services; and consultation services in the aquaculture, agriculture, poultry, and veterinary fields. The company was formerly known as SSK Lifestyles Limited and changed its name to Genesis IBRC India Limited in January 2018. Genesis IBRC India Limited was incorporated in 1992 and is based in Denduluru, India. Read more
-
Incorporated
1992
-
Chairman
--
-
Managing Director
--
-
Headquarters
Mumbai, Maharashtra
-
Website
Looking for more details about Genesis IBRC India Ltd.’s IPO? Explore our IPO Details page.
Annual Reports
FAQs for Genesis IBRC India
What is the current share price of Genesis IBRC India Ltd Today?
The share price of Genesis IBRC India Ltd is ₹113.25 (BSE) as of 18-Jun-2026 IST. Genesis IBRC India Ltd has given a return of 460.37% in the last 1 years.
What is the current PB & PE ratio of Genesis IBRC India Ltd?
Since, TTM earnings of Genesis IBRC India Ltd is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
6.80
|
2.79
|
|
2024
|
0.00
|
3.38
|
|
2023
|
0.00
|
1.57
|
|
2022
|
0.00
|
1.35
|
|
2021
|
0.00
|
0.00
|
What is the 52 Week High and Low of Genesis IBRC India Ltd?
The 52-week high and low of Genesis IBRC India Ltd are Rs 184.90 and Rs 21.22 as of 18-Jun-2026.
What is the market cap of Genesis IBRC India Ltd?
Genesis IBRC India Ltd has a market capitalisation of ₹ 512 Cr as on 18-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Genesis IBRC India Ltd?
Before investing in Genesis IBRC India Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.